Vaccine manufacturing
Where vaccine
innovation thrives
With over a century of vaccine production experience, Canada offers a thriving ecosystem that supports early-stage research to large-scale manufacturing.
Global companies like Moderna, Pfizer and Sanofi choose Canada for its scientific excellence and efficient regulatory environment. Home to the world’s most educated workforce, you’ll find a large pool of life sciences talent to bring your vaccines from discovery to market.
Health Canada provides a streamlined and rigorous approval process, ensuring that vaccines are safe, effective and of high quality. The process reduces time-to-market so companies can scale up new products quickly and efficiently.
Join the many companies choosing Canada as a reliable, high-growth destination for vaccine manufacturing.
Canadian leadership in vaccines
Strategic destination for vaccine manufacturing
Canada is building a resilient ecosystem for next-gen vaccine technologies, including mRNA, protein-based and plant-based platforms. Global companies are leveraging Canadian expertise to research, develop and commercialize new vaccines. For investors, the country offers a strategic opportunity to accelerate commercialization and reduce risk.
Strong public-private partnerships are at the heart of Canada’s next-gen vaccine production leadership. These partnerships and investments include:
Health research funding: The Canadian Institutes of Health Research invests over $1 billion each year in health researchers and projects, giving the industry access to top expertise and funding to research, develop and commercialize products.
Human Health Therapeutics Research Centre: This National Research Council centre designs, develops, tests and produces innovative biologics with industry partners. Companies can tap into expertise, pre-clinical R&D, lab support and a clinical trial material facility.
Biologics Manufacturing Centre: This facility offers end-to-end biomanufacturing services. It produces biopharmaceuticals such as viral vector, protein subunit, virus-like particle vaccines and other biologics.
Biomanufacturing and Life Sciences Strategy: The federal government is investing in mRNA, monoclonal antibodies and AI-driven health solutions, with more than $2.5 billion committed to 43 projects since 2020.
Canada investment highlight
Global vaccine leaders investing in Canada
Major global companies investing in Canada’s thriving vaccine industry include:
Moderna is establishing its first mRNA manufacturing facility outside the U.S. in Montréal. This $180 million investment will produce up to 100 million doses per year, building resilience to manage future pandemic responses.
Resilience Biotechnologies, a next-gen vaccine manufacturing company, has expanded its Mississauga site with a $205 million investment to modernize operations and improve national pandemic preparedness.
Sanofi opened a new $800 million state-of-the-art pediatric and adult vaccine manufacturing facility for whooping cough (pertussis) at its Toronto Campus. It is the largest vaccine manufacturing site in Canada, exporting to 60 markets worldwide.
“We are proud of our heritage in Canada, going back over a century. We remain committed to investments and innovation that improve people’s lives around the world. We look forward to continuing our collaboration with Canadian authorities as we pursue our common goal of ensuring timely access for patients to innovative medicines and vaccines, ensuring better health outcomes for Canadians for another 110 years.”
Stephanie Veyrun-Manetti, Sanofi General Manager US and Global Brand Lead
Why choose Canada
Robust industry regulations and intellectual property protections
Life sciences talent pipeline with vaccine and therapeutics expertise
Low costs for biotech, clinical trials and product testing
Lowest overall tax rate on new investment in the G7
Explore Canada’s biomanufacturing and life sciences sector
Let’s work together
At Invest in Canada, we are dedicated to your company’s success. Our team is your trusted guide to investing in Canada. We get to know your business, offer insights and information and connect you with the right people and places to support your decision.